{"symbol":"ABT","fiscalQuarter":"Q4-2011","reportDate":"2012-01-25","reportTime":"BMO","status":"reported","company":{"name":"Abbott Laboratories","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/ABT/earnings/Q4-2011","postBrief":{"headline":"Abbott Laboratories Beats on EPS, Stock Down 1.34%","keyNumbers":[{"metric":"EPS","actual":"$1.45","expected":"N/A","surprise":"+0.69%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Unknown","keyQuotes":[],"summary":"No transcript is on record, and the analysis is based on numerical results only."},"guidanceChanges":{"summary":"No forward guidance data is available.","changes":[]},"whatItMeans":"Abbott Laboratories reported an EPS of $1.45, beating expectations slightly. However, the stock fell by 1.34% following the earnings report, indicating that investors may have been looking for more comprehensive insights or guidance, which were not provided in this release.","metaDescription":"Abbott Laboratories (ABT) Q4 2011 earnings: EPS beat by 0.69%. Stock down 1.34%. Full breakdown."}}